Sort   by:  
 Page size 
UnknownAre the Healthy Vulnerable? Cytomegalovirus Seropositivity in Healthy Adults Is Associated With Accelerated Epigenetic Age and Immune Dysregulation.
Not available
S-EPMC8344607 | biostudies-literature
UnknownA Human In Vitro Model to Study Adenoviral Receptors and Virus Cell Interactions.
Not available
S-EPMC8909167 | biostudies-literature
UnknownHuman immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination.
Not available
S-EPMC538688 | biostudies-literature
UnknownImprovements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy.
Not available
S-EPMC3874356 | biostudies-literature
UnknownAldosterone Breakthrough for the Prediction of Treatment Response to Mineralocorticoid Receptor Antagonists.
Not available
S-EPMC12309941 | biostudies-literature
UnknownDynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection.
Not available
S-EPMC8429924 | biostudies-literature
UnknownClinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Not available
S-EPMC9238543 | biostudies-literature
UnknownGrapevine Trunk Diseases in Greece: Disease Incidence and Fungi Involved in Discrete Geographical Zones and Varieties.
Not available
S-EPMC10817465 | biostudies-literature
UnknownAssociation between rs174537 FADS1 polymorphism and immune cell profiles in abdominal and femoral subcutaneous adipose tissue: an exploratory study in adults with obesity.
Not available
S-EPMC7894460 | biostudies-literature
UnknownDolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study.
Not available
S-EPMC4091579 | biostudies-literature
Sort   by:  
 Page size